German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer

European Journal of Cancer

Volumn 49, Issue 10, 2013, Pages 2277-2283

[No Author Info available]

Author keywords

ACOSOG Z0011; Axillary clearance; Breast cancer surgery; Consensus statement; Local therapy; Macrometastasis

Indexed keywords

ARTICLE; AUSTRIA; BREAST CANCER; CANCER STAGING; CLINICAL PRACTICE; CONSENSUS; FOLLOW UP; GERMANY; HISTOPATHOLOGY; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; PRIORITY JOURNAL; SENTINEL LYMPH NODE METASTASIS; SWITZERLAND;

AUSTRIA; AXILLA; BREAST NEOPLASMS; FEMALE; GERMANY; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOADJUVANT THERAPY; SENTINEL LYMPH NODE BIOPSY; SWITZERLAND;

EID: 84878377905     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.01.034     Document Type: Article

References (27)

1. A. Goldhirsch, W.C. Wood, and A.S. Coates Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 Ann Oncol 22 2011 1736 1747
2. M. Hubalek, R. Bartsch, and M. Gnant Axillary dissection in the case of positive sentinel lymph nodes: results of the Innsbruck consensus conference Geburtshilfe Frauenheilkd 72 2012 299 304
3. M. Knauer, M. Gnant, and F. Fitzal Results of the first Austrian multidisciplinary expert panel on controversies in local treatment of breast cancer Breast Care 7 2012 61 66
4. A. Wockel, and R. Kreienberg First revision of the German S3 guideline 'diagnosis, therapy, and follow-up of breast cancer' Breast Care 3 2008 82 86
5. N. Patani, and K. Mokbel Clinical significance of sentinel lymph node isolated tumour cells in breast cancer Breast Cancer Res Treat 127 2011 325 334
6. M. de Boer, C.H. van Deurzen, and J.A. van Dijck Micrometastases or isolated tumor cells and the outcome of breast cancer N Engl J Med 361 2009 653 663
7. N.M. Hansen, B. Grube, and X. Ye Impact of micrometastases in the sentinel node of patients with invasive breast cancer J Clin Oncol 27 2009 4679 4684
8. M.C. van Rijk, J.L. Peterse, and O.E. Nieweg Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes Cancer 107 2006 467 471
9. G. Cserni, D. Gregori, and F. Merletti Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer Br J Surg 91 2004 1245 1252
10. M.J. Pepels, M. de Boer, and P. Bult Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells Ann Surg 255 2012 116 121
11. V. Galimberti, E. Botteri, and C. Chifu Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer? Breast Cancer Res Treat 131 2012 819 825
12. K.Y. Bilimoria, D.J. Bentrem, and N.M. Hansen Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer J Clin Oncol 27 2009 2946 2953
13. A.E. Giuliano, K.K. Hunt, and K.V. Ballman Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial JAMA 305 2011 569 575
14. A.E. Giuliano, L. McCall, and P. Beitsch Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial Ann Surg 252 2010 426 432 discussion 432-423
15. B. Fisher, J.H. Jeong, and S. Anderson Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation N Engl J Med 347 2002 567 575
16. C.M. Rudenstam, D. Zahrieh, and J.F. Forbes Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93 J Clin Oncol 24 2006 337 344
17. G. Martelli, R. Miceli, and M.G. Daidone Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up Ann Surg Oncol 18 2011 125 133
18. M.E. Straver, P. Meijnen, and G. van Tienhoven Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial Ann Surg Oncol 17 2010 1854 1861
19. T. Shigekawa, I. Sugitani, and H. Takeuchi Axillary ultrasound examination is useful for selecting patients optimally suited for sentinel lymph node biopsy after primary systemic chemotherapy Am J Surg 204 2012 487 493
20. Y. Xing, M. Foy, and D.D. Cox Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer Br J Surg 93 2006 539 546
21. D.N. Krag, S.J. Anderson, and T.B. Julian Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial Lancet Oncol 8 2007 881 888
22. K.K. Hunt, M. Yi, and E.A. Mittendorf Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients Ann Surg 250 2009 558 566
23. E.P. Mamounas, A. Brown, and S. Anderson Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27 J Clin Oncol 23 2005 2694 2702
24. A. Chung, and A. Giuliano Axillary staging in the neoadjuvant setting Ann Surg Oncol 17 2010 2401 2410
25. H.M. Kuerer, A.A. Sahin, and K.K. Hunt Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy Ann Surg 230 1999 72 78
26. F. Fitzal, O. Riedl, and M. Mittlbock Oncologic safety of breast conserving surgery after tumour downsizing by neoadjuvant therapy: a retrospective single centre cohort study Breast Cancer Res Treat 127 2011 121 128
27. W.F. Symmans, F. Peintinger, and C. Hatzis Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy J Clin Oncol 25 2007 4414 4422